母体Graves病结局:一项基于人群的母婴配对队列研究
该研究将以色列国家新生儿甲状腺功能筛查数据与一家三级医疗中心电子病历链接,纳入2011至2021年间出生的足月母婴配对,分析母亲既往或活动性Graves病对母婴结局的影响。共103899对母婴中292名(0.3%)母亲有既往或活动性Graves病;母亲Graves病与辅助生殖技术使用、妊娠期高血压、蛋白尿、剖宫产、胎膜早破及胎盘异常风险升高相关,其婴儿调整出生体重z评分更低且小于胎龄儿比例更高。新生儿甲状腺功能仅在母亲妊娠期疾病活动时受影响。
要点
- 母亲活动性Graves病与新生儿筛查总甲状腺素(tT4)水平升高相关,非活动性者无显著影响。
- 母亲Graves病与辅助生殖技术使用、妊娠期高血压、蛋白尿、剖宫产、胎膜早破及胎盘异常风险升高相关。
- 母亲Graves病与婴儿调整出生体重z评分降低及小于胎龄儿风险升高相关。
核心结论
- 新生儿甲状腺功能水平仅在母亲Graves病于妊娠期活动时受影响;母亲Graves病还与母婴配对不良结局风险升高相关。
研究设计与样本
- 基于人群的母婴配对队列研究,链接以色列国家新生儿甲状腺功能筛查数据集与一家三级医疗中心电子病历,纳入2011至2021年间出生的足月母婴配对,共103899对,其中292名(0.3%)母亲有既往或活动性Graves病。
主要发现
- 前向多变量线性回归显示Graves病对新生儿筛查总甲状腺素(tT4)水平无显著影响(p=0.252)。
- 活动性Graves病母亲所生婴儿的新生儿筛查tT4水平高于以色列一般人群(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Graves' disease has been associated with adverse pregnancy, labor and delivery, and neonatal outcomes. Thyroid function levels, assessed during newborn screening (NBS), can serve as indicators of the adaptation in the hypothalamic-pituitary-thyroid axis. We utilized data from the national thyroid NBS program to investigate the characteristics of the mother-infant dyad of term infants born to mothers with past or active Graves' disease. Methods: The dataset of the Israeli NBS for thyroid function was linked with the electronic records of a tertiary medical center to generate a unified database of mothers and their term infants born between 2011 and 2021. The MDClone big data platform extracted maternal, pregnancy, disease course, labor and delivery, and neonatal characteristics of the mother-infant dyads. Results: Out of 103,899 registered mother-infant dyads, 292 (0.3%) mothers had past or active Graves' disease. A forward multivariate linear regression demonstrated that Graves' disease did not significantly affect NBS total thyroxine (tT4) levels (p = 0.252). NBS tT4 levels in infants born to mothers with active Graves' disease were higher than those observed in the general Israeli population (p < 0.001). Mothers with Graves' disease more frequently used assisted reproductive technology (12.7% vs. 9.0%, respectively, p = 0.012; odds ratio [OR] = 1.46 [CI 1.03-2.07], p = 0.031), and had more gestational hypertension (3.9% vs. 1.1%, p < 0.001; OR = 3.53 [CI 1.92-6.47], p < 0.001), proteinuria (2.5% vs. 0.9%, p < 0.001; OR = 3.03 [CI 1.43-6.45], p = 0.004), cesarean sections (26.4% vs. 19.7%, p = 0.029; OR = 1.46 [CI 1.13-1.90], p = 0.004), prelabor rupture of membranes (15.4% vs. 4.1%, p < 0.001; OR = 4.3 [CI 3.13-5.91], p < 0.001), and placental abnormalities (5.1% vs. 2.0%, p < 0.001; OR = 2.64 [CI 1.57-4.44]; p < 0.001). Their infants had lower adjusted birthweight z-scores (-0.18 ± 0.94 vs. -0.03 ± 0.90, p = 0.007) and were more likely to be small for gestational age (12.0% vs. 8.1%, p = 0.005; OR = 1.54 [CI 1.08-2.19], p = 0.018). Conclusions: Neonatal thyroid function levels were affected by maternal Graves' disease only when the disease was active during gestation. Moreover, maternal Graves' disease was also associated with an increased risk of adverse outcomes for the mother-infant dyad.
引用
- Cohen-Sela E, Brener A, Raviv O, et al. Outcomes in Maternal Graves' Disease: A Population-Based Mother-Infant Dyad Cohort Study. Thyroid. 2023. PMID: 38009210. doi:10.1089/thy.2023.0291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。